{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:58:37Z","timestamp":1791503917652,"version":"4.3.4"},"reference-count":179,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,19]]},"DOI":"10.7759\/cureus.69764","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T01:27:16Z","timestamp":1726795636000},"source":"Crossref","is-referenced-by-count":13,"title":["Current Insights on Treatment Adherence in Prevalent Dermatological Conditions and Strategies To Optimize Adherence Rates"],"prefix":"10.7759","author":[{"given":"Nicoleta","family":"C\u00eerstea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Radu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosmin","family":"Vesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei Flavius","family":"Radu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa Florina","family":"Bungau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia Mirela","family":"Tit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Delia","family":"Nistor Cseppento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra Georgiana","family":"Tarce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Gabriela","family":"Bungau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/23743735221077523","article-title":"Patient adherence to health care provider recommendations and medication among free clinic patients","volume":"9","author":"Panahi S","year":"2022","unstructured":"Panahi S, Rathi N, Hurley J, Sundrud J, Lucero M, Kamimura A. Patient adherence to health care provider recommendations and medication among free clinic patients. J Patient Exp. 2022, 9:23743735221077523. 10.1177\/23743735221077523","journal-title":"J Patient Exp"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/jvc2.379","article-title":"Adherence to treatment in dermatology: literature review","volume":"3","author":"Lo A","year":"2024","unstructured":"Lo A, Lovell K, Greenzaid JD, Oscherwitz ME, Feldman SR. Adherence to treatment in dermatology: literature review. JEADV Clin Pract. 2024, 3:10.1002\/jvc2.379","journal-title":"JEADV Clin Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S230921","article-title":"Treatment adherence among patients with five dermatological diseases and four treatment types - a cross-sectional study","volume":"13","author":"Alsubeeh NA","year":"2019","unstructured":"Alsubeeh NA, Alsharafi AA, Ahamed SS, Alajlan A. Treatment adherence among patients with five dermatological diseases and four treatment types - a cross-sectional study. Patient Prefer Adherence. 2019, 13:2029-2038. 10.2147\/PPA.S230921","journal-title":"Patient Prefer Adherence"},{"key":"ref4","unstructured":"Adherence to long-term therapies\u202f. evidence for action. (2003). Accessed: April 11, 2024: https:\/\/iris.who.int\/handle\/10665\/42682."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15913","article-title":"A systematic review of factors influencing treatment adherence in chronic inflammatory skin disease - strategies for optimizing treatment outcome","volume":"33","author":"Eicher L","year":"2019","unstructured":"Eicher L, Knop M, Aszodi N, Senner S, French LE, Wollenberg A. A systematic review of factors influencing treatment adherence in chronic inflammatory skin disease - strategies for optimizing treatment outcome. J Eur Acad Dermatol Venereol. 2019, 33:2253-2263. 10.1111\/jdv.15913","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-7-55","article-title":"Patient adherence to medical treatment: a review of reviews","volume":"7","author":"van Dulmen S","year":"2007","unstructured":"van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res. 2007, 7:55. 10.1186\/1472-6963-7-55","journal-title":"BMC Health Serv Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0253-5","article-title":"Treatment adherence intervention studies in dermatology and guidance on how to support adherence","volume":"18","author":"Feldman SR","year":"2017","unstructured":"Feldman SR, Vrijens B, Gieler U, Piaserico S, Puig L, van de Kerkhof P. Treatment adherence intervention studies in dermatology and guidance on how to support adherence. Am J Clin Dermatol. 2017, 18:253-271. 10.1007\/s40257-017-0253-5","journal-title":"Am J Clin Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glq027","article-title":"Poor adherence to medications may be associated with falls","volume":"65","author":"Berry SD","year":"2010","unstructured":"Berry SD, Quach L, Procter-Gray E, et al.. Poor adherence to medications may be associated with falls. J Gerontol A Biol Sci Med Sci. 2010, 65:553-558. 10.1093\/gerona\/glq027","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1017\/cbo9780511543579.001","article-title":"Adherence to treatment","author":"Horne R","year":"2007","unstructured":"Horne R. Adherence to treatment. Cambridge Handbook of Psychology, Health and Medicine. Ayers S, Baum A, McManus C, Newman S, Wallston K, Weinman J, West R, (ed): Cambridge University Press, Cambridge; 2007. 415-421. 10.1017\/cbo9780511543579.001"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4081\/jphr.2016.762","article-title":"Intentional and unintentional medication non-adherence in hypertension: the role of health literacy, empowerment and medication beliefs","volume":"5","author":"N\u00e1fr\u00e1di L","year":"2016","unstructured":"N\u00e1fr\u00e1di L, Galimberti E, Nakamoto K, Schulz PJ. Intentional and unintentional medication non-adherence in hypertension: the role of health literacy, empowerment and medication beliefs. J Public Health Res. 2016, 5:762. 10.4081\/jphr.2016.762","journal-title":"J Public Health Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2006.07.010","article-title":"Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper","volume":"44","author":"Lehane E","year":"2007","unstructured":"Lehane E, McCarthy G. Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper. Int J Nurs Stud. 2007, 44:1468-1477. 10.1016\/j.ijnurstu.2006.07.010","journal-title":"Int J Nurs Stud"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-27809-0","article-title":"Treatment Adherence in Dermatology","author":"Feldman SR","year":"2020","unstructured":"Feldman SR, Cline A, Pona A, Kolli SS. Treatment Adherence in Dermatology. Springer, Berlin, Heidelberg; 2020. 10.1007\/978-3-030-27809-0"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S147420","article-title":"Barriers to treatment: describing them from a different perspective","volume":"12","author":"Devine F","year":"2018","unstructured":"Devine F, Edwards T, Feldman SR. Barriers to treatment: describing them from a different perspective. Patient Prefer Adherence. 2018, 12:129-133. 10.2147\/PPA.S147420","journal-title":"Patient Prefer Adherence"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002183","article-title":"Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and meta-analysis","volume":"13","author":"Shubber Z","year":"2016","unstructured":"Shubber Z, Mills EJ, Nachega JB, et al.. Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and meta-analysis. PLoS Med. 2016, 13:e1002183. 10.1371\/journal.pmed.1002183","journal-title":"PLoS Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/0956462412472807","article-title":"Factors affecting antiretroviral therapy adherence among HIV-positive pregnant and postpartum women: an adapted systematic review","volume":"24","author":"Vitalis D","year":"2013","unstructured":"Vitalis D. Factors affecting antiretroviral therapy adherence among HIV-positive pregnant and postpartum women: an adapted systematic review. Int J STD AIDS. 2013, 24:427-432. 10.1177\/0956462412472807","journal-title":"Int J STD AIDS"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.26226\/morressier.59d5184bd462b80296ca32c3","article-title":"Access and adherence to medication among people with diabetes in Brazil: evidences from PNAUM","volume":"20","author":"Meiners MA","year":"2017","unstructured":"Meiners MA, Tavares NL, Guimar\u00e3es LP, et al.. Access and adherence to medication among people with diabetes in Brazil: evidences from PNAUM. Brazilian J Epidemiol. 2017, 20:445-459. 10.26226\/morressier.59d5184bd462b80296ca32c3","journal-title":"Brazilian J Epidemiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12349","article-title":"Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence","volume":"41","author":"Shirneshan E","year":"2016","unstructured":"Shirneshan E, Kyrychenko P, Matlin OS, Avila JP, Brennan TA, Shrank WH. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence. J Clin Pharm Ther. 2016, 41:64-69. 10.1111\/jcpt.12349","journal-title":"J Clin Pharm Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-015-0499-y","article-title":"Racial and ethnic disparities in cost-related medication non-adherence among cancer survivors","volume":"10","author":"Lee M","year":"2016","unstructured":"Lee M, Salloum RG. Racial and ethnic disparities in cost-related medication non-adherence among cancer survivors. J Cancer Surviv. 2016, 10:534-544. 10.1007\/s11764-015-0499-y","journal-title":"J Cancer Surviv"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.15386\/mpr-1201","article-title":"An overview of the common methods used to measure treatment adherence","volume":"92","author":"Anghel LA","year":"2019","unstructured":"Anghel LA, Farcas AM, Oprean RN. An overview of the common methods used to measure treatment adherence. Med Pharm Rep. 2019, 92:117-122. 10.15386\/mpr-1201","journal-title":"Med Pharm Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.adengl.2013.04.004","article-title":"Health-related quality of life, patient satisfaction, and adherence to treatment in patients with moderate or severe atopic dermatitis on maintenance therapy: the CONDA-SAT study","volume":"104","author":"Torrelo A","year":"2013","unstructured":"Torrelo A, Ortiz J, Alomar A, Ros S, Pedrosa E, Cuervo J. Health-related quality of life, patient satisfaction, and adherence to treatment in patients with moderate or severe atopic dermatitis on maintenance therapy: the CONDA-SAT study. Actas Dermosifiliogr. 2013, 104:409-417. 10.1016\/j.adengl.2013.04.004","journal-title":"Actas Dermosifiliogr"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01565.x","article-title":"Adherence to treatment in patients with psoriasis","volume":"20","author":"Richards HL","year":"2006","unstructured":"Richards HL, Fortune DG, Griffiths CE. Adherence to treatment in patients with psoriasis. J Eur Acad Dermatol Venereol. 2006, 20:370-379. 10.1111\/j.1468-3083.2006.01565.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16895","article-title":"The Pharmacist's role in dermatology: patient medication adherence","volume":"50","author":"Pathak GN","year":"2023","unstructured":"Pathak GN, Chandy RJ, Shah R, Feldman SR. The Pharmacist's role in dermatology: patient medication adherence. J Dermatol. 2023, 50:1099-1107. 10.1111\/1346-8138.16895","journal-title":"J Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-022-01719-6","article-title":"Health literacy and medication adherence in psoriasis patients: a survey in Iran","volume":"23","author":"Avazeh Y","year":"2022","unstructured":"Avazeh Y, Rezaei S, Bastani P, Mehralian G. Health literacy and medication adherence in psoriasis patients: a survey in Iran. BMC Prim Care. 2022, 23:113. 10.1186\/s12875-022-01719-6","journal-title":"BMC Prim Care"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09253.x","article-title":"Adherence to topical dermatological therapy: lessons from oral drug treatment","volume":"161","author":"Gupta G","year":"2009","unstructured":"Gupta G, Mallefet P, Kress DW, Sergeant A. Adherence to topical dermatological therapy: lessons from oral drug treatment. Br J Dermatol. 2009, 161:221-227. 10.1111\/j.1365-2133.2009.09253.x","journal-title":"Br J Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06174.x","article-title":"Better medication adherence results in greater improvement in severity of psoriasis","volume":"151","author":"Carroll CL","year":"2004","unstructured":"Carroll CL, Feldman SR, Camacho FT, Balkrishnan R. Better medication adherence results in greater improvement in severity of psoriasis. Br J Dermatol. 2004, 151:895-897. 10.1111\/j.1365-2133.2004.06174.x","journal-title":"Br J Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-0488.20.06684-5","article-title":"Apremilast for psoriasis treatment","volume":"155","author":"Carrascosa JM","year":"2020","unstructured":"Carrascosa JM, Del-Alcazar E. Apremilast for psoriasis treatment. G Ital Dermatol Venereol. 2020, 155:421-433. 10.23736\/S0392-0488.20.06684-5","journal-title":"G Ital Dermatol Venereol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/bjbs.2023.11314","article-title":"Dermatopathology and the diagnosis of fungal infections","volume":"80","author":"Howell SA","year":"2023","unstructured":"Howell SA. Dermatopathology and the diagnosis of fungal infections. Br J Biomed Sci. 2023, 80:11314. 10.3389\/bjbs.2023.11314","journal-title":"Br J Biomed Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2020.10.003","article-title":"The global, regional, and national burden of fungal skin diseases in 195 countries and territories: a cross-sectional analysis from the Global Burden of Disease Study 2017","volume":"2","author":"Urban K","year":"2021","unstructured":"Urban K, Chu S, Scheufele C, Giesey RL, Mehrmal S, Uppal P, Delost GR. The global, regional, and national burden of fungal skin diseases in 195 countries and territories: a cross-sectional analysis from the Global Burden of Disease Study 2017. JAAD Int. 2021, 2:22-27. 10.1016\/j.jdin.2020.10.003","journal-title":"JAAD Int"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases-estimate precision","volume":"3","author":"Bongomin F","year":"2017","unstructured":"Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi (Basel). 2017, 3:57. 10.3390\/jof3040057","journal-title":"J Fungi (Basel)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.36547\/ft.2019.2.2.3-5","article-title":"Review of fungal skin infections and their invasion","volume":"2","author":"Hilles A","year":"2019","unstructured":"Hilles A, Mahmood S, Kaderi M, Hashim R. Review of fungal skin infections and their invasion. Fungal Territ. 2019, 2:3. 10.36547\/ft.2019.2.2.3-5","journal-title":"Fungal Territ"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.fgb.2019.103254","article-title":"Facilitators of adaptation and antifungal resistance mechanisms in clinically relevant fungi","volume":"132","author":"Hokken MW","year":"2019","unstructured":"Hokken MW, Zwaan BJ, Melchers WJ, Verweij PE. Facilitators of adaptation and antifungal resistance mechanisms in clinically relevant fungi. Fungal Genet Biol. 2019, 132:103254. 10.1016\/j.fgb.2019.103254","journal-title":"Fungal Genet Biol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000630","article-title":"Fungal infections of the skin and soft tissue","volume":"33","author":"Gunaydin SD","year":"2020","unstructured":"Gunaydin SD, Arikan-Akdagli S, Akova M. Fungal infections of the skin and soft tissue. Curr Opin Infect Dis. 2020, 33:130-136. 10.1097\/QCO.0000000000000630","journal-title":"Curr Opin Infect Dis"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-019-0322-2","article-title":"Drug resistance and tolerance in fungi","volume":"18","author":"Berman J","year":"2020","unstructured":"Berman J, Krysan DJ. Drug resistance and tolerance in fungi. Nat Rev Microbiol. 2020, 18:319-331. 10.1038\/s41579-019-0322-2","journal-title":"Nat Rev Microbiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s13671-023-00386-9","article-title":"Emerging fungal infections and cutaneous manifestations in immunosuppressed patients","volume":"12","author":"Varghese JA","year":"2023","unstructured":"Varghese JA, Guhan S, Zheng L. Emerging fungal infections and cutaneous manifestations in immunosuppressed patients. Curr Dermatol Rep. 2023, 12:69-81. 10.1007\/s13671-023-00386-9","journal-title":"Curr Dermatol Rep"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/01.nurse.0000334629.68169.e3","article-title":"Increasing patient adherence in antifungal infection treatment: once-daily dosing of sertaconazole","volume":"2","author":"Weinberg JM","year":"2009","unstructured":"Weinberg JM. Increasing patient adherence in antifungal infection treatment: once-daily dosing of sertaconazole. J Clin Aesthet Dermatol. 2009, 2:38-42. 10.1097\/01.nurse.0000334629.68169.e3","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg L","year":"2005","unstructured":"Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005, 353:487-497. 10.1056\/NEJMra050100","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis: a brief overview","volume":"21","author":"Raharja A","year":"2021","unstructured":"Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clin Med (Lond). 2021, 21:170-173. 10.7861\/clinmed.2021-0257","journal-title":"Clin Med (Lond)"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041320","article-title":"Psoriasis","volume":"352","author":"Sch\u00f6n MP","year":"2005","unstructured":"Sch\u00f6n MP, Boehncke WH. Psoriasis. N Engl J Med. 2005, 352:1899-1912. 10.1056\/NEJMra041320","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S136986","article-title":"New insight into the pathogenesis of nail psoriasis and overview of treatment strategies","volume":"11","author":"Ventura A","year":"2017","unstructured":"Ventura A, Mazzeo M, Gaziano R, Galluzzo M, Bianchi L, Campione E. New insight into the pathogenesis of nail psoriasis and overview of treatment strategies. Drug Des Devel Ther. 2017, 11:2527-2535. 10.2147\/DDDT.S136986","journal-title":"Drug Des Devel Ther"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052935","article-title":"Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011","volume":"7","author":"Armstrong AW","year":"2012","unstructured":"Armstrong AW, Schupp C, Wu J, Bebo B. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011. PLoS One. 2012, 7:e52935. 10.1371\/journal.pone.0052935","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-4-35","article-title":"Quality of life in patients with psoriasis","volume":"4","author":"Bhosle MJ","year":"2006","unstructured":"Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health Qual Life Outcomes. 2006, 4:35. 10.1186\/1477-7525-4-35","journal-title":"Health Qual Life Outcomes"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12039","article-title":"Adherence to medication in patients with psoriasis: a systematic literature review","volume":"168","author":"Thorneloe RJ","year":"2013","unstructured":"Thorneloe RJ, Bundy C, Griffiths CE, Ashcroft DM, Cordingley L. Adherence to medication in patients with psoriasis: a systematic literature review. Br J Dermatol. 2013, 168:20-31. 10.1111\/bjd.12039","journal-title":"Br J Dermatol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.4.408","article-title":"Objective assessment of compliance with psoriasis treatment","volume":"140","author":"Zaghloul SS","year":"2004","unstructured":"Zaghloul SS, Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch Dermatol. 2004, 140:408-414. 10.1001\/archderm.140.4.408","journal-title":"Arch Dermatol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2011.607425","article-title":"Factors affecting adherence to treatment of psoriasis: comparing biologic therapy to other modalities","volume":"24","author":"Chan SA","year":"2013","unstructured":"Chan SA, Hussain F, Lawson LG, Ormerod AD. Factors affecting adherence to treatment of psoriasis: comparing biologic therapy to other modalities. J Dermatolog Treat. 2013, 24:64-69. 10.3109\/09546634.2011.607425","journal-title":"J Dermatolog Treat"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S117006","article-title":"Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature","volume":"10","author":"Belinch\u00f3n I","year":"2016","unstructured":"Belinch\u00f3n I, Rivera R, Blanch C, Comellas M, Liz\u00e1n L. Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature. Patient Prefer Adherence. 2016, 10:2357-2367. 10.2147\/PPA.S117006","journal-title":"Patient Prefer Adherence"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05037.x","article-title":"Self-medication and adherence to treatment in psoriasis","volume":"51","author":"Kivelevitch DN","year":"2012","unstructured":"Kivelevitch DN, Tahhan PV, Bourren P, Kogan NN, Gusis SE, Rodr\u00edguez EA. Self-medication and adherence to treatment in psoriasis. Int J Dermatol. 2012, 51:416-419. 10.1111\/j.1365-4632.2011.05037.x","journal-title":"Int J Dermatol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06357.x","article-title":"Objective assessment of compliance with treatments in acne","volume":"152","author":"Zaghloul SS","year":"2005","unstructured":"Zaghloul SS, Cunliffe WJ, Goodfield MJ. Objective assessment of compliance with treatments in acne. Br J Dermatol. 2005, 152:1015-1021. 10.1111\/j.1365-2133.2005.06357.x","journal-title":"Br J Dermatol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.12.021","article-title":"Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis","volume":"55","author":"Brown KK","year":"2006","unstructured":"Brown KK, Rehmus WE, Kimball AB. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol. 2006, 55:607-613. 10.1016\/j.jaad.2005.12.021","journal-title":"J Am Acad Dermatol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04525.x","article-title":"Adherence to topical treatment in psoriasis: a systematic literature review","volume":"26","author":"Devaux S","year":"2012","unstructured":"Devaux S, Castela A, Archier E, et al.. Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012, 26:61-67. 10.1111\/j.1468-3083.2012.04525.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.01.052","article-title":"Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use","volume":"51","author":"Carroll CL","year":"2004","unstructured":"Carroll CL, Feldman SR, Camacho FT, Manuel JC, Balkrishnan R. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004, 51:212-216. 10.1016\/j.jaad.2004.01.052","journal-title":"J Am Acad Dermatol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2005.01329.x","article-title":"How patients experience psoriasis: results from a European survey","volume":"19","author":"Fou\u00e9r\u00e9 S","year":"2005","unstructured":"Fou\u00e9r\u00e9 S, Adjadj L, Pawin H. How patients experience psoriasis: results from a European survey. J Eur Acad Dermatol Venereol. 2005, 19:2-6. 10.1111\/j.1468-3083.2005.01329.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200607040-00004","article-title":"Pharmionics in dermatology: a review of topical medication adherence","volume":"7","author":"Lee IA","year":"2006","unstructured":"Lee IA, Maibach HI. Pharmionics in dermatology: a review of topical medication adherence. Am J Clin Dermatol. 2006, 7:231-236. 10.2165\/00128071-200607040-00004","journal-title":"Am J Clin Dermatol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2017.29.5.559","article-title":"Adherence to topical therapies for the treatment of psoriasis: surveys of physicians and patients","volume":"29","author":"Choi JW","year":"2017","unstructured":"Choi JW, Kim BR, Youn SW. Adherence to topical therapies for the treatment of psoriasis: surveys of physicians and patients. Ann Dermatol. 2017, 29:559-564. 10.5021\/ad.2017.29.5.559","journal-title":"Ann Dermatol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.26226\/morressier.595a9c52d462b80296c9f810","article-title":"Differential drug survival of biologic therapies for the treatment of psoriasis: a prospective observational cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)","volume":"135","author":"Warren RB","year":"2015","unstructured":"Warren RB, Smith CH, Yiu ZN, et al.. Differential drug survival of biologic therapies for the treatment of psoriasis: a prospective observational cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR). J Invest Dermatol. 2015, 135:2632-2640. 10.26226\/morressier.595a9c52d462b80296c9f810","journal-title":"J Invest Dermatol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12548","article-title":"Survival rates of biological therapies for psoriasis treatment in real-world clinical practice: a Canadian multicentre retrospective study","volume":"59","author":"Marinas JE","year":"2018","unstructured":"Marinas JE, Kim WB, Shahbaz A, Qiang JK, Greaves S, Yeung J. Survival rates of biological therapies for psoriasis treatment in real-world clinical practice: a Canadian multicentre retrospective study. Australas J Dermatol. 2018, 59:e11-e14. 10.1111\/ajd.12548","journal-title":"Australas J Dermatol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.06.053","article-title":"Drug utilization patterns and adherence in patients on systemic medications for the treatment of psoriasis: a retrospective, comparative cohort study","volume":"79","author":"Dommasch ED","year":"2018","unstructured":"Dommasch ED, Lee MP, Joyce CJ, Garry EM, Gagne JJ. Drug utilization patterns and adherence in patients on systemic medications for the treatment of psoriasis: a retrospective, comparative cohort study. J Am Acad Dermatol. 2018, 79:1061.e1-1068.e1. 10.1016\/j.jaad.2018.06.053","journal-title":"J Am Acad Dermatol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.01.048","article-title":"Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population","volume":"74","author":"Doshi JA","year":"2016","unstructured":"Doshi JA, Takeshita J, Pinto L, et al.. Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population. J Am Acad Dermatol. 2016, 74:1057.e4-1065.e4. 10.1016\/j.jaad.2016.01.048","journal-title":"J Am Acad Dermatol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2018.1479725","article-title":"Treatment patterns, adherence, and persistence among psoriasis patients treated with biologics in a real-world setting, overall and by disease severity","volume":"30","author":"Murage MJ","year":"2019","unstructured":"Murage MJ, Anderson A, Casso D, et al.. Treatment patterns, adherence, and persistence among psoriasis patients treated with biologics in a real-world setting, overall and by disease severity. J Dermatolog Treat. 2019, 30:141-149. 10.1080\/09546634.2018.1479725","journal-title":"J Dermatolog Treat"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15086","article-title":"Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis","volume":"176","author":"Thorneloe RJ","year":"2017","unstructured":"Thorneloe RJ, Bundy C, Griffiths CE, Ashcroft DM, Cordingley L. Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis. Br J Dermatol. 2017, 176:667-676. 10.1111\/bjd.15086","journal-title":"Br J Dermatol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3109\/09546630903085328","article-title":"Conversations on psoriasis--what patients want and what physicians can provide: a qualitative look at patient and physician expectations","volume":"21","author":"Uhlenhake EE","year":"2010","unstructured":"Uhlenhake EE, Kurkowski D, Feldman SR. Conversations on psoriasis--what patients want and what physicians can provide: a qualitative look at patient and physician expectations. J Dermatolog Treat. 2010, 21:6-12. 10.3109\/09546630903085328","journal-title":"J Dermatolog Treat"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.2147\/PTT.S109557","article-title":"Psoriasis patients' experiences concerning medical adherence to treatment with topical corticosteroids","volume":"6","author":"Svendsen MT","year":"2016","unstructured":"Svendsen MT, Andersen KE, Andersen F, Hansen J, Potteg\u00e5rd A, Johannessen H. Psoriasis patients' experiences concerning medical adherence to treatment with topical corticosteroids. Psoriasis (Auckl). 2016, 6:113-119. 10.2147\/PTT.S109557","journal-title":"Psoriasis (Auckl)"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15466","article-title":"A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol\/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP)","volume":"177","author":"Reich K","year":"2017","unstructured":"Reich K, Zschocke I, Bachelez H, et al.. A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol\/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP). Br J Dermatol. 2017, 177:197-205. 10.1111\/bjd.15466","journal-title":"Br J Dermatol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2004.01107.x","article-title":"Quality of care in patients with psoriasis: an initial clinical study of an international disease management programme","volume":"19","author":"de Korte J","year":"2005","unstructured":"de Korte J, Van Onselen J, Kownacki S, Sprangers MA, Bos JD. Quality of care in patients with psoriasis: an initial clinical study of an international disease management programme. J Eur Acad Dermatol Venereol. 2005, 19:35-41. 10.1111\/j.1468-3083.2004.01107.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.10119.x","article-title":"Patients' views of nurse prescribing: effects on care, concordance and medicine taking","volume":"164","author":"Courtenay M","year":"2011","unstructured":"Courtenay M, Carey N, Stenner K, Lawton S, Peters J. Patients' views of nurse prescribing: effects on care, concordance and medicine taking. Br J Dermatol. 2011, 164:396-401. 10.1111\/j.1365-2133.2010.10119.x","journal-title":"Br J Dermatol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06979.x","article-title":"Nurse-led care in dermatology: a review of the literature","volume":"154","author":"Courtenay M","year":"2006","unstructured":"Courtenay M, Carey N. Nurse-led care in dermatology: a review of the literature. Br J Dermatol. 2006, 154:1-6. 10.1111\/j.1365-2133.2005.06979.x","journal-title":"Br J Dermatol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1328100","article-title":"Role of personalized medication training in improving efficacy and adherence to a topical therapy in psoriatic patients","volume":"28","author":"Caldarola G","year":"2017","unstructured":"Caldarola G, De Simone C, Moretta G, Poscia A, Peris K. Role of personalized medication training in improving efficacy and adherence to a topical therapy in psoriatic patients. J Dermatolog Treat. 2017, 28:722-725. 10.1080\/09546634.2017.1328100","journal-title":"J Dermatolog Treat"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000908","article-title":"General and skin-specific health-related quality of life in patients with atopic dermatitis before and during the COVID-19 pandemic","volume":"33","author":"Koszor\u00fa K","year":"2022","unstructured":"Koszor\u00fa K, Hajdu K, Brodszky V, et al.. General and skin-specific health-related quality of life in patients with atopic dermatitis before and during the COVID-19 pandemic. Dermatitis. 2022, 33:S92-S103. 10.1097\/DER.0000000000000908","journal-title":"Dermatitis"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/s0091-6749(99)70536-1","article-title":"Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood","volume":"103","author":"Williams H","year":"1999","unstructured":"Williams H, Robertson C, Stewart A, et al.. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol. 1999, 103:125-138. 10.1016\/s0091-6749(99)70536-1","journal-title":"J Allergy Clin Immunol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.251","article-title":"Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health","volume":"131","author":"Shaw TE","year":"2011","unstructured":"Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol. 2011, 131:67-73. 10.1038\/jid.2010.251","journal-title":"J Invest Dermatol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2020.02.006","article-title":"Japanese guidelines for atopic dermatitis 2020","volume":"69","author":"Katoh N","year":"2020","unstructured":"Katoh N, Ohya Y, Ikeda M, et al.. Japanese guidelines for atopic dermatitis 2020. Allergol Int. 2020, 69:356-369. 10.1016\/j.alit.2020.02.006","journal-title":"Allergol Int"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.02.060","article-title":"Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS","volume":"82","author":"Silverberg JI","year":"2020","unstructured":"Silverberg JI, Yosipovitch G, Simpson EL, et al.. Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS. J Am Acad Dermatol. 2020, 82:1328-1336. 10.1016\/j.jaad.2020.02.060","journal-title":"J Am Acad Dermatol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2023.100195","article-title":"Optimal use of Jak inhibitors and biologics for atopic dermatitis on the basis of the current evidence","volume":"3","author":"Kamata M","year":"2023","unstructured":"Kamata M, Tada Y. Optimal use of Jak inhibitors and biologics for atopic dermatitis on the basis of the current evidence. JID Innov. 2023, 3:100195. 10.1016\/j.xjidi.2023.100195","journal-title":"JID Innov"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18345","article-title":"European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy","volume":"36","author":"Wollenberg A","year":"2022","unstructured":"Wollenberg A, Kinberger M, Arents B, et al.. European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy. J Eur Acad Dermatol Venereol. 2022, 36:1409-1431. 10.1111\/jdv.18345","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.08.009","article-title":"JAK inhibitors in the treatment of atopic dermatitis","volume":"148","author":"Chovatiya R","year":"2021","unstructured":"Chovatiya R, Paller AS. JAK inhibitors in the treatment of atopic dermatitis. J Allergy Clin Immunol. 2021, 148:927-940. 10.1016\/j.jaci.2021.08.009","journal-title":"J Allergy Clin Immunol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.05.073","article-title":"Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis","volume":"56","author":"Krejci-Manwaring J","year":"2007","unstructured":"Krejci-Manwaring J, Tusa MG, Carroll C, et al.. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007, 56:211-216. 10.1016\/j.jaad.2006.05.073","journal-title":"J Am Acad Dermatol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00821-y","article-title":"Clinical efficacy of a digital intervention for patients with atopic dermatitis: a prospective single-center study","volume":"12","author":"Gudmundsd\u00f3ttir SL","year":"2022","unstructured":"Gudmundsd\u00f3ttir SL, Ballarini T, \u00c1mundad\u00f3ttir ML, et al.. Clinical efficacy of a digital intervention for patients with atopic dermatitis: a prospective single-center study. Dermatol Ther (Heidelb). 2022, 12:2601-2611. 10.1007\/s13555-022-00821-y","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.03.045","article-title":"One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic","volume":"59","author":"Storm A","year":"2008","unstructured":"Storm A, Andersen SE, Benfeldt E, Serup J. One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol. 2008, 59:27-33. 10.1016\/j.jaad.2008.03.045","journal-title":"J Am Acad Dermatol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1350256","article-title":"High rates of secondary non-adherence causes decreased efficacy of 0.1% topical tacrolimus in adult eczema patients: results from a multicenter clinical trial","volume":"29","author":"Yang MY","year":"2018","unstructured":"Yang MY, Jin H, Shim WH, et al.. High rates of secondary non-adherence causes decreased efficacy of 0.1% topical tacrolimus in adult eczema patients: results from a multicenter clinical trial. J Dermatolog Treat. 2018, 29:129-134. 10.1080\/09546634.2017.1350256","journal-title":"J Dermatolog Treat"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.09.031","article-title":"Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis","volume":"60","author":"Wilson R","year":"2009","unstructured":"Wilson R, Camacho F, Clark AR, Young T, Inabinet R, Yentzer BA, Feldman SR. Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis. J Am Acad Dermatol. 2009, 60:166-168. 10.1016\/j.jaad.2008.09.031","journal-title":"J Am Acad Dermatol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.5070\/d31910020029","article-title":"Adherence to a five day treatment course of topical fluocinonide 0.1% cream in atopic dermatitis","volume":"19","author":"Hix E","year":"2013","unstructured":"Hix E, Gustafson CJ, O\u2019Neill JL, et al.. Adherence to a five day treatment course of topical fluocinonide 0.1% cream in atopic dermatitis. Dermatol Online J. 2013, 19:20029. 10.5070\/d31910020029","journal-title":"Dermatol Online J"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.12788\/j.sder.2017.035","article-title":"Atopic dermatitis: skin care and topical therapies","volume":"36","author":"Fleischer DM","year":"2017","unstructured":"Fleischer DM, Udkoff J, Borok J, et al.. Atopic dermatitis: skin care and topical therapies. Semin Cutan Med Surg. 2017, 36:104-110. 10.12788\/j.sder.2017.035","journal-title":"Semin Cutan Med Surg"},{"key":"ref82","article-title":"Adherence to topical corticosteroids and moisturisers in adults with endogenous eczema in Singapore","volume":"23","author":"Huynh R","year":"2015","unstructured":"Huynh R, Wong H, Aw D, Toh M. Adherence to topical corticosteroids and moisturisers in adults with endogenous eczema in Singapore. Hong Kong J Dermatology Venereol. 2015, 23:161-174.","journal-title":"Hong Kong J Dermatology Venereol"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.6280","article-title":"Measuring and improving adherence to crisaborole 2% ointment in patients with atopic dermatitis","volume":"21","author":"Snyder S","year":"2022","unstructured":"Snyder S, Collins A, Cline A, Bashyam A, Unrue E, Feldman S, Strowd L. Measuring and improving adherence to crisaborole 2% ointment in patients with atopic dermatitis. J Drugs Dermatol. 2022, 21:1043-1048. 10.36849\/JDD.6280","journal-title":"J Drugs Dermatol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2011.01493.x","article-title":"Potential barriers to adherence in pediatric dermatology","volume":"28","author":"Ellis RM","year":"2011","unstructured":"Ellis RM, Koch LH, McGuire E, Williams JV. Potential barriers to adherence in pediatric dermatology. Pediatr Dermatol. 2011, 28:242-244. 10.1111\/j.1525-1470.2011.01493.x","journal-title":"Pediatr Dermatol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1111\/jan.12133","article-title":"Managing childhood eczema: qualitative study exploring carers' experiences of barriers and facilitators to treatment adherence","volume":"69","author":"Santer M","year":"2013","unstructured":"Santer M, Burgess H, Yardley L, et al.. Managing childhood eczema: qualitative study exploring carers' experiences of barriers and facilitators to treatment adherence. J Adv Nurs. 2013, 69:2493-2501. 10.1111\/jan.12133","journal-title":"J Adv Nurs"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3038.2002.01005.x","article-title":"Evaluation of a parental training program for the management of childhood atopic dermatitis","volume":"13","author":"Staab D","year":"2002","unstructured":"Staab D, von Rueden U, Kehrt R, Erhart M, Wenninger K, Kamtsiuris P, Wahn U. Evaluation of a parental training program for the management of childhood atopic dermatitis. Pediatr Allergy Immunol. 2002, 13:84-90. 10.1034\/j.1399-3038.2002.01005.x","journal-title":"Pediatr Allergy Immunol"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13667","article-title":"A survey to assess use patterns and perceptions of efficacy of eczema action plans among pediatric dermatologists","volume":"35","author":"Stringer T","year":"2018","unstructured":"Stringer T, Yin HS, Oza VS. A survey to assess use patterns and perceptions of efficacy of eczema action plans among pediatric dermatologists. Pediatr Dermatol. 2018, 35:e432-e434. 10.1111\/pde.13667","journal-title":"Pediatr Dermatol"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.2267","article-title":"Parental response to written eczema action plans in children with eczema","volume":"148","author":"Rork JF","year":"2012","unstructured":"Rork JF, Sheehan WJ, Gaffin JM, Timmons KG, Sidbury R, Schneider LC, Phipatanakul W. Parental response to written eczema action plans in children with eczema. Arch Dermatol. 2012, 148:391-392. 10.1001\/archdermatol.2011.2267","journal-title":"Arch Dermatol"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.368","article-title":"A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis","volume":"146","author":"Sagransky MJ","year":"2010","unstructured":"Sagransky MJ, Yentzer BA, Williams LL, Clark AR, Taylor SL, Feldman SR. A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. Arch Dermatol. 2010, 146:1428-1430. 10.1001\/archdermatol.2010.368","journal-title":"Arch Dermatol"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16054","article-title":"Burden of illness, medication adherence, and unmet medical needs in Japanese patients with atopic dermatitis: a retrospective analysis of a cross-sectional questionnaire survey","volume":"48","author":"Kamei K","year":"2021","unstructured":"Kamei K, Hirose T, Yoshii N, Tanaka A. Burden of illness, medication adherence, and unmet medical needs in Japanese patients with atopic dermatitis: a retrospective analysis of a cross-sectional questionnaire survey. J Dermatol. 2021, 48:1491-1498. 10.1111\/1346-8138.16054","journal-title":"J Dermatol"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.1130","article-title":"Medicare part D payments for topical steroids: rising costs and potential savings","volume":"153","author":"Song H","year":"2017","unstructured":"Song H, Adamson A, Mostaghimi A. Medicare part D payments for topical steroids: rising costs and potential savings. JAMA Dermatol. 2017, 153:755-759. 10.1001\/jamadermatol.2017.1130","journal-title":"JAMA Dermatol"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174936","article-title":"Non-conventional therapeutical approaches to acne vulgaris related to its association with metabolic disorders","volume":"923","author":"Bungau SG","year":"2022","unstructured":"Bungau SG, Tit DM, Vesa CM, et al.. Non-conventional therapeutical approaches to acne vulgaris related to its association with metabolic disorders. Eur J Pharmacol. 2022, 923:174936. 10.1016\/j.ejphar.2022.174936","journal-title":"Eur J Pharmacol"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-019-01908-x","article-title":"From pathogenesis of acne vulgaris to anti-acne agents","volume":"311","author":"Cong TX","year":"2019","unstructured":"Cong TX, Hao D, Wen X, Li XH, He G, Jiang X. From pathogenesis of acne vulgaris to anti-acne agents. Arch Dermatol Res. 2019, 311:337-349. 10.1007\/s00403-019-01908-x","journal-title":"Arch Dermatol Res"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.2147\/AHMT.S55832","article-title":"The epidemiology of acne vulgaris in late adolescence","volume":"7","author":"Lynn DD","year":"2016","unstructured":"Lynn DD, Umari T, Dunnick CA, Dellavalle RP. The epidemiology of acne vulgaris in late adolescence. Adolesc Health Med Ther. 2016, 7:13-25. 10.2147\/AHMT.S55832","journal-title":"Adolesc Health Med Ther"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15419","article-title":"Acne relapses: impact on quality of life and productivity","volume":"33","author":"Dreno B","year":"2019","unstructured":"Dreno B, Bordet C, Seite S, Taieb C. Acne relapses: impact on quality of life and productivity. J Eur Acad Dermatol Venereol. 2019, 33:937-943. 10.1111\/jdv.15419","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-023-00789-1","article-title":"Targeting inflammation in acne: current treatments and future prospects","volume":"24","author":"Cruz S","year":"2023","unstructured":"Cruz S, Vecerek N, Elbuluk N. Targeting inflammation in acne: current treatments and future prospects. Am J Clin Dermatol. 2023, 24:681-694. 10.1007\/s40257-023-00789-1","journal-title":"Am J Clin Dermatol"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115003","article-title":"Oxidative stress and metabolic syndrome in acne vulgaris: Pathogenetic connections and potential role of dietary supplements and phytochemicals","volume":"164","author":"Bungau AF","year":"2023","unstructured":"Bungau AF, Radu AF, Bungau SG, Vesa CM, Tit DM, Endres LM. Oxidative stress and metabolic syndrome in acne vulgaris: Pathogenetic connections and potential role of dietary supplements and phytochemicals. Biomed Pharmacother. 2023, 164:115003. 10.1016\/j.biopha.2023.115003","journal-title":"Biomed Pharmacother"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1111\/j.1473-2165.2010.00490.x","article-title":"Medication adherence among acne patients: a review","volume":"9","author":"Lott R","year":"2010","unstructured":"Lott R, Taylor SL, O'Neill JL, Krowchuk DP, Feldman SR. Medication adherence among acne patients: a review. J Cosmet Dermatol. 2010, 9:160-166. 10.1111\/j.1473-2165.2010.00490.x","journal-title":"J Cosmet Dermatol"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.6144","article-title":"The role of the physician in patient perceptions of barriers to primary adherence with acne medications","volume":"154","author":"Ryskina KL","year":"2018","unstructured":"Ryskina KL, Goldberg E, Lott B, Hermann D, Barbieri JS, Lipoff JB. The role of the physician in patient perceptions of barriers to primary adherence with acne medications. JAMA Dermatol. 2018, 154:456-459. 10.1001\/jamadermatol.2017.6144","journal-title":"JAMA Dermatol"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1159\/000332847","article-title":"Acne management in Japan: study of patient adherence","volume":"223","author":"Miyachi Y","year":"2011","unstructured":"Miyachi Y, Hayashi N, Furukawa F, Akamatsu H, Matsunaga K, Watanabe S, Kawashima M. Acne management in Japan: study of patient adherence. Dermatology. 2011, 223:174-181. 10.1159\/000332847","journal-title":"Dermatology"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-013-0016-x","article-title":"Medication adherence, healthcare costs and utilization associated with acne drugs in Medicaid enrollees with acne vulgaris","volume":"14","author":"Tan X","year":"2013","unstructured":"Tan X, Al-Dabagh A, Davis SA, Lin HC, Balkrishnan R, Chang J, Feldman SR. Medication adherence, healthcare costs and utilization associated with acne drugs in Medicaid enrollees with acne vulgaris. Am J Clin Dermatol. 2013, 14:243-251. 10.1007\/s40257-013-0016-x","journal-title":"Am J Clin Dermatol"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12713","article-title":"Medication adherence in children and adolescents with acne vulgaris in medicaid: a retrospective study analysis","volume":"33","author":"Hester C","year":"2016","unstructured":"Hester C, Park C, Chung J, Balkrishnan R, Feldman S, Chang J. Medication adherence in children and adolescents with acne vulgaris in medicaid: a retrospective study analysis. Pediatr Dermatol. 2016, 33:49-55. 10.1111\/pde.12713","journal-title":"Pediatr Dermatol"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-014-0063-y","article-title":"Medical adherence to acne therapy: a systematic review","volume":"15","author":"Snyder S","year":"2014","unstructured":"Snyder S, Crandell I, Davis SA, Feldman SR. Medical adherence to acne therapy: a systematic review. Am J Clin Dermatol. 2014, 15:87-94. 10.1007\/s40257-014-0063-y","journal-title":"Am J Clin Dermatol"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-014-0099-z","article-title":"Recent advances in acne pathogenesis: implications for therapy","volume":"15","author":"Das S","year":"2014","unstructured":"Das S, Reynolds RV. Recent advances in acne pathogenesis: implications for therapy. Am J Clin Dermatol. 2014, 15:479-488. 10.1007\/s40257-014-0099-z","journal-title":"Am J Clin Dermatol"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200102010-00002","article-title":"Electronic monitoring in medication adherence measurement. Implications for dermatology","volume":"2","author":"Koehler AM","year":"2001","unstructured":"Koehler AM, Maibach HI. Electronic monitoring in medication adherence measurement. Implications for dermatology. Am J Clin Dermatol. 2001, 2:7-12. 10.2165\/00128071-200102010-00002","journal-title":"Am J Clin Dermatol"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.01.883","article-title":"Topical antimicrobial acne treatment tolerability: a meaningful factor in treatment adherence?","volume":"71","author":"Bartlett KB","year":"2014","unstructured":"Bartlett KB, Davis SA, Feldman SR. Topical antimicrobial acne treatment tolerability: a meaningful factor in treatment adherence?. J Am Acad Dermatol. 2014, 71:581.e2-582.e2. 10.1016\/j.jaad.2014.01.883","journal-title":"J Am Acad Dermatol"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2010.04416.x","article-title":"Large-scale worldwide observational study of adherence with acne therapy","volume":"49","author":"Dr\u00e9no B","year":"2010","unstructured":"Dr\u00e9no B, Thiboutot D, Gollnick H, et al.. Large-scale worldwide observational study of adherence with acne therapy. Int J Dermatol. 2010, 49:448-456. 10.1111\/j.1365-4632.2010.04416.x","journal-title":"Int J Dermatol"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2006.00078.x","article-title":"Tricks for improving compliance with acne therapy","volume":"19","author":"Baldwin HE","year":"2006","unstructured":"Baldwin HE. Tricks for improving compliance with acne therapy. Dermatol Ther. 2006, 19:224-236. 10.1111\/j.1529-8019.2006.00078.x","journal-title":"Dermatol Ther"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.12.017","article-title":"Guidelines of care for the management of acne vulgaris","volume":"90","author":"Reynolds RV","year":"2024","unstructured":"Reynolds RV, Yeung H, Cheng CE, et al.. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024, 90:1006.e1-1006.e30. 10.1016\/j.jaad.2023.12.017","journal-title":"J Am Acad Dermatol"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S46051","article-title":"Improving adherence to acne treatment: the emerging role of application software","volume":"7","author":"Park C","year":"2014","unstructured":"Park C, Kim G, Patel I, Chang J, Tan X. Improving adherence to acne treatment: the emerging role of application software. Clin Cosmet Investig Dermatol. 2014, 7:65-72. 10.2147\/CCID.S46051","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.4274\/imj.galenos.2018.43179","article-title":"The effect of medical education and counselling on treatment adherence and disease severity in patients with acne vulgaris: a non-randomised interventional study","volume":"78","author":"Ling WY","year":"2023","unstructured":"Ling WY, Loo CH, Nurul Shafaril Niza MA, Tan JL, Norazlima MA, Tan WC. The effect of medical education and counselling on treatment adherence and disease severity in patients with acne vulgaris: a non-randomised interventional study. Med J Malaysia. 2023, 78:263-269. 10.4274\/imj.galenos.2018.43179","journal-title":"Med J Malaysia"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2016.1181256","article-title":"Adherence in dermatology","volume":"28","author":"Ahn CS","year":"2017","unstructured":"Ahn CS, Culp L, Huang WW, Davis SA, Feldman SR. Adherence in dermatology. J Dermatolog Treat. 2017, 28:94-103. 10.1080\/09546634.2016.1181256","journal-title":"J Dermatolog Treat"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13675","article-title":"A consensus-based practical and daily guide for the treatment of acne patients","volume":"30","author":"Gollnick HP","year":"2016","unstructured":"Gollnick HP, Bettoli V, Lambert J, et al.. A consensus-based practical and daily guide for the treatment of acne patients. J Eur Acad Dermatol Venereol. 2016, 30:1480-1490. 10.1111\/jdv.13675","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1080\/09546630802570818","article-title":"Basic drug information given by physicians is deficient, and patients' knowledge low","volume":"20","author":"Storm A","year":"2009","unstructured":"Storm A, Benfeldt E, Andersen SE, Andersen J. Basic drug information given by physicians is deficient, and patients' knowledge low. J Dermatolog Treat. 2009, 20:190-193. 10.1080\/09546630802570818","journal-title":"J Dermatolog Treat"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.0504a04","article-title":"Oral and written counseling is a useful instrument to improve short-term adherence to treatment in acne patients: a randomized controlled trial","volume":"5","author":"Navarrete-Dechent C","year":"2015","unstructured":"Navarrete-Dechent C, Curi-Tuma M, Nicklas C, C\u00e1rdenas C, P\u00e9rez-Cotapos ML, Salomone C. Oral and written counseling is a useful instrument to improve short-term adherence to treatment in acne patients: a randomized controlled trial. Dermatol Pract Concept. 2015, 5:13-16. 10.5826\/dpc.0504a04","journal-title":"Dermatol Pract Concept"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.5254","article-title":"Frequency of primary nonadherence to acne treatment","volume":"151","author":"Anderson KL","year":"2015","unstructured":"Anderson KL, Dothard EH, Huang KE, Feldman SR. Frequency of primary nonadherence to acne treatment. JAMA Dermatol. 2015, 151:623-626. 10.1001\/jamadermatol.2014.5254","journal-title":"JAMA Dermatol"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S26314","article-title":"The effect of reminder systems on patients' adherence to treatment","volume":"6","author":"Fenerty SD","year":"2012","unstructured":"Fenerty SD, West C, Davis SA, Kaplan SG, Feldman SR. The effect of reminder systems on patients' adherence to treatment. Patient Prefer Adherence. 2012, 6:127-135. 10.2147\/PPA.S26314","journal-title":"Patient Prefer Adherence"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.2147\/AHMT.S56065","article-title":"Internet-based adherence interventions for treatment of chronic disorders in adolescents","volume":"6","author":"Bass AM","year":"2015","unstructured":"Bass AM, Farhangian ME, Feldman SR. Internet-based adherence interventions for treatment of chronic disorders in adolescents. Adolesc Health Med Ther. 2015, 6:91-99. 10.2147\/AHMT.S56065","journal-title":"Adolesc Health Med Ther"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.2196\/mhealth.6425","article-title":"Economic evaluation of text-messaging and smartphone-based interventions to improve medication adherence in adolescents with chronic health conditions: a systematic review","volume":"4","author":"Badawy SM","year":"2016","unstructured":"Badawy SM, Kuhns LM. Economic evaluation of text-messaging and smartphone-based interventions to improve medication adherence in adolescents with chronic health conditions: a systematic review. JMIR Mhealth Uhealth. 2016, 4:e121. 10.2196\/mhealth.6425","journal-title":"JMIR Mhealth Uhealth"},{"key":"ref120","article-title":"Acne counseling to improve adherence","volume":"81","author":"Thiboutot D","year":"2008","unstructured":"Thiboutot D, Dr\u00e9no B, Layton A. Acne counseling to improve adherence. Cutis. 2008, 81:81-86.","journal-title":"Cutis"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2016.1117605","article-title":"Tazarotene foam, 0.1%, for the treatment of acne","volume":"15","author":"Smith JA","year":"2016","unstructured":"Smith JA, Narahari S, Hill D, Feldman SR. Tazarotene foam, 0.1%, for the treatment of acne. Expert Opin Drug Saf. 2016, 15:99-103. 10.1517\/14740338.2016.1117605","journal-title":"Expert Opin Drug Saf"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.04.005","article-title":"Adherence to topical therapy increases around the time of office visits","volume":"57","author":"Feldman SR","year":"2007","unstructured":"Feldman SR, Camacho FT, Krejci-Manwaring J, Carroll CL, Balkrishnan R. Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol. 2007, 57:81-83. 10.1016\/j.jaad.2007.04.005","journal-title":"J Am Acad Dermatol"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.2843","article-title":"Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials","volume":"149","author":"Davis SA","year":"2013","unstructured":"Davis SA, Feldman SR. Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials. JAMA Dermatol. 2013, 149:490-491. 10.1001\/jamadermatol.2013.2843","journal-title":"JAMA Dermatol"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1080\/00182370.2023.2347094","article-title":"Chronic Urticaria","author":"Dabija D","year":"2023","unstructured":"Dabija D, Tadi P, Danosos GN. Chronic Urticaria. StatPearls Publishing, Treasure Island, FL; 2023. 10.1080\/00182370.2023.2347094"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2017.9.3.212","article-title":"Prevalence and risk factors of urticaria with a focus on chronic urticaria in children","volume":"9","author":"Lee SJ","year":"2017","unstructured":"Lee SJ, Ha EK, Jee HM, et al.. Prevalence and risk factors of urticaria with a focus on chronic urticaria in children. Allergy Asthma Immunol Res. 2017, 9:212-219. 10.4168\/aair.2017.9.3.212","journal-title":"Allergy Asthma Immunol Res"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.02.064","article-title":"Prevalence estimates for chronic urticaria in the United States: a sex- and age-adjusted population analysis","volume":"81","author":"Wertenteil S","year":"2019","unstructured":"Wertenteil S, Strunk A, Garg A. Prevalence estimates for chronic urticaria in the United States: a sex- and age-adjusted population analysis. J Am Acad Dermatol. 2019, 81:152-156. 10.1016\/j.jaad.2019.02.064","journal-title":"J Am Acad Dermatol"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.5415\/apallergy.2015.5.4.197","article-title":"A study of treatment adherence and quality of life among adults with chronic urticaria in Singapore","volume":"5","author":"Heng JK","year":"2015","unstructured":"Heng JK, Koh LJ, Toh MP, Aw DC. A study of treatment adherence and quality of life among adults with chronic urticaria in Singapore. Asia Pac Allergy. 2015, 5:197-202. 10.5415\/apallergy.2015.5.4.197","journal-title":"Asia Pac Allergy"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12971","article-title":"Transient improvement of urticaria induces poor adherence as assessed by Morisky Medication Adherence Scale-8","volume":"42","author":"Kaneko S","year":"2015","unstructured":"Kaneko S, Masuda K, Hiragun T, et al.. Transient improvement of urticaria induces poor adherence as assessed by Morisky Medication Adherence Scale-8. J Dermatol. 2015, 42:1078-1082. 10.1111\/1346-8138.12971","journal-title":"J Dermatol"},{"key":"ref129","article-title":"Why a health systems approach?","author":"Bigdeli M","year":"2014","unstructured":"Bigdeli M, Garabedian LF, Javadi D, Campbell S. Why a health systems approach?. Medicines in health systems: advancing access, affordability and appropriate use  . Bigdeli M, Peters DH, Wagner AK (ed): WHO Library Cataloguing-in-Publication Data, 2014. 17-25."},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2016.02.009","article-title":"Reasons for intentional guideline non-adherence: a systematic review","volume":"89","author":"Arts DL","year":"2016","unstructured":"Arts DL, Voncken AG, Medlock S, Abu-Hanna A, van Weert HC. Reasons for intentional guideline non-adherence: a systematic review. Int J Med Inform. 2016, 89:55-62. 10.1016\/j.ijmedinf.2016.02.009","journal-title":"Int J Med Inform"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1111\/jan.13148","article-title":"Systematic review of patient preference and adherence to the correct use of graduated compression stockings to prevent deep vein thrombosis in surgical patients","volume":"73","author":"Wade R","year":"2017","unstructured":"Wade R, Paton F, Woolacott N. Systematic review of patient preference and adherence to the correct use of graduated compression stockings to prevent deep vein thrombosis in surgical patients. J Adv Nurs. 2017, 73:336-348. 10.1111\/jan.13148","journal-title":"J Adv Nurs"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.00091","article-title":"Determinants of patient adherence: a review of systematic reviews","volume":"4","author":"Kardas P","year":"2013","unstructured":"Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013, 4:91. 10.3389\/fphar.2013.00091","journal-title":"Front Pharmacol"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2015.1009362","article-title":"Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model","volume":"27","author":"Holtzman CW","year":"2015","unstructured":"Holtzman CW, Shea JA, Glanz K, et al.. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model. AIDS Care. 2015, 27:817-828. 10.1080\/09540121.2015.1009362","journal-title":"AIDS Care"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-015-1174-8","article-title":"Type 2 diabetes patients' and providers' differing perspectives on medication nonadherence: a qualitative meta-synthesis","volume":"15","author":"Brundisini F","year":"2015","unstructured":"Brundisini F, Vanstone M, Hulan D, DeJean D, Giacomini M. Type 2 diabetes patients' and providers' differing perspectives on medication nonadherence: a qualitative meta-synthesis. BMC Health Serv Res. 2015, 15:516. 10.1186\/s12913-015-1174-8","journal-title":"BMC Health Serv Res"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2016.01.001","article-title":"Patient education: identifying risks and self-management approaches for adherence and sudden unexpected death in epilepsy","volume":"34","author":"Shafer PO","year":"2016","unstructured":"Shafer PO, Buchhalter J. Patient education: identifying risks and self-management approaches for adherence and sudden unexpected death in epilepsy. Neurol Clin. 2016, 34:443-456. 10.1016\/j.ncl.2016.01.001","journal-title":"Neurol Clin"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1097\/HCR.0000000000000232","article-title":"Examining patient outcome quality indicators based on wait time from referral to entry into cardiac rehabilitation: a pilot observational study","volume":"37","author":"Kehler DS","year":"2017","unstructured":"Kehler DS, Kent D, Beaulac J, et al.. Examining patient outcome quality indicators based on wait time from referral to entry into cardiac rehabilitation: a pilot observational study. J Cardiopulm Rehabil Prev. 2017, 37:250-256. 10.1097\/HCR.0000000000000232","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1177\/1362361315586136","article-title":"The relationship between waiting times and 'adherence' to the Scottish Intercollegiate Guidelines Network 98 guideline in autism spectrum disorder diagnostic services in Scotland","volume":"20","author":"McKenzie K","year":"2016","unstructured":"McKenzie K, Forsyth K, O'Hare A, McClure I, Rutherford M, Murray A, Irvine L. The relationship between waiting times and 'adherence' to the Scottish Intercollegiate Guidelines Network 98 guideline in autism spectrum disorder diagnostic services in Scotland. Autism. 2016, 20:395-401. 10.1177\/1362361315586136","journal-title":"Autism"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12128","article-title":"Real-world factors affecting adherence to insulin therapy in patients with type 1 or type 2 diabetes mellitus: a systematic review","volume":"30","author":"Davies MJ","year":"2013","unstructured":"Davies MJ, Gagliardino JJ, Gray LJ, Khunti K, Mohan V, Hughes R. Real-world factors affecting adherence to insulin therapy in patients with type 1 or type 2 diabetes mellitus: a systematic review. Diabet Med. 2013, 30:512-524. 10.1111\/dme.12128","journal-title":"Diabet Med"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002488","article-title":"Barriers to treatment access for Chagas disease in Mexico","volume":"7","author":"Manne JM","year":"2013","unstructured":"Manne JM, Snively CS, Ramsey JM, Salgado MO, B\u00e4rnighausen T, Reich MR. Barriers to treatment access for Chagas disease in Mexico. PLoS Negl Trop Dis. 2013, 7:e2488. 10.1371\/journal.pntd.0002488","journal-title":"PLoS Negl Trop Dis"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2012.711756","article-title":"Topical drug delivery systems in dermatology: a review of patient adherence issues","volume":"9","author":"Tan X","year":"2012","unstructured":"Tan X, Feldman SR, Chang J, Balkrishnan R. Topical drug delivery systems in dermatology: a review of patient adherence issues. Expert Opin Drug Deliv. 2012, 9:1263-1271. 10.1517\/17425247.2012.711756","journal-title":"Expert Opin Drug Deliv"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.5070\/d3203021762","article-title":"Are topical keratolytic agents needed in the treatment of scalp psoriasis?","volume":"20","author":"Shokeen D","year":"2014","unstructured":"Shokeen D, O\u2019Neill JL, Taheri A, Feldman SR. Are topical keratolytic agents needed in the treatment of scalp psoriasis?. Dermatol Online J. 2014, 20:15. 10.5070\/d3203021762","journal-title":"Dermatol Online J"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.4321\/s1885-642x2006000300001","article-title":"The effects of pharmacist interventions on patients with polypharmacy","volume":"4","author":"Chumney EC","year":"2006","unstructured":"Chumney EC, Robinson LC. The effects of pharmacist interventions on patients with polypharmacy. Pharm Pract (Granada). 2006, 4:103-109. 10.4321\/s1885-642x2006000300001","journal-title":"Pharm Pract (Granada)"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12445","article-title":"Non-adherence and measures to improve adherence in the topical treatment of psoriasis","volume":"28","author":"Zschocke I","year":"2014","unstructured":"Zschocke I, Mrowietz U, Karakasili E, Reich K. Non-adherence and measures to improve adherence in the topical treatment of psoriasis. J Eur Acad Dermatol Venereol. 2014, 28:4-9. 10.1111\/jdv.12445","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S200058","article-title":"Assessing methods of measuring medication adherence in chronically ill children-a narrative review","volume":"13","author":"Al-Hassany L","year":"2019","unstructured":"Al-Hassany L, Kloosterboer SM, Dierckx B, Koch BC. Assessing methods of measuring medication adherence in chronically ill children-a narrative review. Patient Prefer Adherence. 2019, 13:1175-1189. 10.2147\/PPA.S200058","journal-title":"Patient Prefer Adherence"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/217047","article-title":"Medication adherence measures: an overview","volume":"2015","author":"Lam WY","year":"2015","unstructured":"Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015, 2015:217047. 10.1155\/2015\/217047","journal-title":"Biomed Res Int"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.2217\/ijr.10.15","article-title":"Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"5","author":"de Achaval S","year":"2010","unstructured":"de Achaval S, Suarez-Almazor ME. Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus. Int J Clin Rheumtol. 2010, 5:313-326. 10.2217\/ijr.10.15","journal-title":"Int J Clin Rheumtol"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.1586\/eci.12.23","article-title":"Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature","volume":"8","author":"van den Bemt BJ","year":"2012","unstructured":"van den Bemt BJ, Zwikker HE, van den Ende CH. Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Expert Rev Clin Immunol. 2012, 8:337-351. 10.1586\/eci.12.23","journal-title":"Expert Rev Clin Immunol"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1016\/j.cptl.2013.09.008","article-title":"The pharmacist role in dermatologic care","volume":"6","author":"Fabbro SK","year":"2014","unstructured":"Fabbro SK, Mostow EN, Helms SE, Kasmer R, Brodell RT. The pharmacist role in dermatologic care. Curr Pharm Teach Learn. 2014, 6:92-105. 10.1016\/j.cptl.2013.09.008","journal-title":"Curr Pharm Teach Learn"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2012.05.005","article-title":"Working in interprofessional primary health care teams: what do pharmacists do?","volume":"9","author":"Farrell B","year":"2013","unstructured":"Farrell B, Ward N, Dore N, Russell G, Geneau R, Evans S. Working in interprofessional primary health care teams: what do pharmacists do?. Res Social Adm Pharm. 2013, 9:288-301. 10.1016\/j.sapharm.2012.05.005","journal-title":"Res Social Adm Pharm"},{"key":"ref150","doi-asserted-by":"publisher","DOI":"10.1093\/ijpp\/riab056","article-title":"Community pharmacists' perceptions and role in the management of common dermatological problems in Lebanon: a cross-sectional study","volume":"29","author":"Chahine B","year":"2021","unstructured":"Chahine B, Cherfane M, Sakr F, Safwan J, Dabbous M, Akel M, Rahal M. Community pharmacists' perceptions and role in the management of common dermatological problems in Lebanon: a cross-sectional study. Int J Pharm Pract. 2021, 29:573-579. 10.1093\/ijpp\/riab056","journal-title":"Int J Pharm Pract"},{"key":"ref151","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-019-00827-1","article-title":"Optimizing pharmaceutical care for pediatric patients with dermatitis: perspectives of parents and pharmacy staff","volume":"41","author":"Koster ES","year":"2019","unstructured":"Koster ES, Philbert D, Wagelaar KR, Galle S, Bouvy ML. Optimizing pharmaceutical care for pediatric patients with dermatitis: perspectives of parents and pharmacy staff. Int J Clin Pharm. 2019, 41:711-718. 10.1007\/s11096-019-00827-1","journal-title":"Int J Clin Pharm"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.1995.tb00706.x","article-title":"Pharmaceutical care for patients with skin diseases: a campaign year at Swedish pharmacies","volume":"20","author":"Hammarstr\u00f6m B","year":"1995","unstructured":"Hammarstr\u00f6m B, Wessling A, Nilsson JL. Pharmaceutical care for patients with skin diseases: a campaign year at Swedish pharmacies. J Clin Pharm Ther. 1995, 20:327-334. 10.1111\/j.1365-2710.1995.tb00706.x","journal-title":"J Clin Pharm Ther"},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2157","article-title":"Corticosteroid phobia among pharmacists regarding atopic dermatitis in children: a national French survey","volume":"96","author":"Raffin D","year":"2016","unstructured":"Raffin D, Giraudeau B, Samimi M, Machet L, Pourrat X, Maruani A. Corticosteroid phobia among pharmacists regarding atopic dermatitis in children: a national French survey. Acta Derm Venereol. 2016, 96:177-180. 10.2340\/00015555-2157","journal-title":"Acta Derm Venereol"},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3220","article-title":"Topical corticosteroid phobia among healthcare professionals using the TOPICOP score","volume":"99","author":"Lambrechts L","year":"2019","unstructured":"Lambrechts L, Gilissen L, Morren MA. Topical corticosteroid phobia among healthcare professionals using the TOPICOP score. Acta Derm Venereol. 2019, 99:1004-1008. 10.2340\/00015555-3220","journal-title":"Acta Derm Venereol"},{"key":"ref155","doi-asserted-by":"publisher","DOI":"10.1177\/1078155220904149","article-title":"Effectiveness of a pharmaceutical instruction video for adherence to dermatopathy treatment in patients with cancer receiving the anti-epidermal growth factor receptor antibody","volume":"26","author":"Sato J","year":"2020","unstructured":"Sato J, Ishikawa H, Yasuda Y, et al.. Effectiveness of a pharmaceutical instruction video for adherence to dermatopathy treatment in patients with cancer receiving the anti-epidermal growth factor receptor antibody. J Oncol Pharm Pract. 2020, 26:1667-1675. 10.1177\/1078155220904149","journal-title":"J Oncol Pharm Pract"},{"key":"ref156","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13708","article-title":"Impact of pharmacists' counseling on caregiver's knowledge in the management of pediatric atopic dermatitis","volume":"36","author":"Cheong JY","year":"2019","unstructured":"Cheong JY, Hie SL, Koh EW, de Souza NN, Koh MJ. Impact of pharmacists' counseling on caregiver's knowledge in the management of pediatric atopic dermatitis. Pediatr Dermatol. 2019, 36:105-109. 10.1111\/pde.13708","journal-title":"Pediatr Dermatol"},{"key":"ref157","doi-asserted-by":"publisher","DOI":"10.1248\/yakushi.17-00118-4","article-title":"Role of pharmacists in topical therapy for onychomycosis in the home-care setting","volume":"138","author":"Yamaura K","year":"2018","unstructured":"Yamaura K, Hayashi N, Imazu Y, Yoneta Y, Uchida E, Suzuki J. Role of pharmacists in topical therapy for onychomycosis in the home-care setting. Yakugaku Zasshi. 2018, 138:615-619. 10.1248\/yakushi.17-00118-4","journal-title":"Yakugaku Zasshi"},{"key":"ref158","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2016.1213353","article-title":"Evaluation of the influence of pharmacists and GPs on patient perceptions of long-term topical corticosteroid use","volume":"28","author":"Farrugia LL","year":"2017","unstructured":"Farrugia LL, Lee A, Fischer G, Blaszczynski A, Carter SR, Smith SD. Evaluation of the influence of pharmacists and GPs on patient perceptions of long-term topical corticosteroid use. J Dermatolog Treat. 2017, 28:112-118. 10.1080\/09546634.2016.1213353","journal-title":"J Dermatolog Treat"},{"key":"ref159","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-021-01241-2","article-title":"Reducing corticosteroid phobia in pharmacy staff and parents of children with atopic dermatitis","volume":"43","author":"Koster ES","year":"2021","unstructured":"Koster ES, Philbert D, Zheng X, Moradi N, de Vries TW, Bouvy ML. Reducing corticosteroid phobia in pharmacy staff and parents of children with atopic dermatitis. Int J Clin Pharm. 2021, 43:1237-1244. 10.1007\/s11096-021-01241-2","journal-title":"Int J Clin Pharm"},{"key":"ref160","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20102","article-title":"Clinical pharmacist role in improving the knowledge and outcomes in patients using isotretinoin: a randomized, controlled study","volume":"9","author":"Alabadallah RY","year":"2023","unstructured":"Alabadallah RY, Hijazi BM, Altawalbeh SM, Oqal M, Almomani BA. Clinical pharmacist role in improving the knowledge and outcomes in patients using isotretinoin: a randomized, controlled study. Heliyon. 2023, 9:e20102. 10.1016\/j.heliyon.2023.e20102","journal-title":"Heliyon"},{"key":"ref161","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000011.pub4","article-title":"Interventions for enhancing medication adherence","volume":"2014","author":"Nieuwlaat R","year":"2014","unstructured":"Nieuwlaat R, Wilczynski N, Navarro T, et al.. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014, 2014:CD000011. 10.1002\/14651858.CD000011.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref162","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13377","article-title":"Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8","volume":"172","author":"Furue M","year":"2015","unstructured":"Furue M, Onozuka D, Takeuchi S, et al.. Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8. Br J Dermatol. 2015, 172:272-275. 10.1111\/bjd.13377","journal-title":"Br J Dermatol"},{"key":"ref163","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.7.912","article-title":"Poor adherence to treatments: a fundamental principle of dermatology","volume":"143","author":"Ali SM","year":"2007","unstructured":"Ali SM, Brodell RT, Balkrishnan R, Feldman SR. Poor adherence to treatments: a fundamental principle of dermatology. Arch Dermatol. 2007, 143:912-915. 10.1001\/archderm.143.7.912","journal-title":"Arch Dermatol"},{"key":"ref164","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocu047","article-title":"Technology-mediated interventions for enhancing medication adherence","volume":"22","author":"Mistry N","year":"2015","unstructured":"Mistry N, Keepanasseril A, Wilczynski NL, Nieuwlaat R, Ravall M, Haynes RB. Technology-mediated interventions for enhancing medication adherence. J Am Med Inform Assoc. 2015, 22:e177-e193. 10.1093\/jamia\/ocu047","journal-title":"J Am Med Inform Assoc"},{"key":"ref165","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1341612","article-title":"eHealth Technologies as an intervention to improve adherence to topical antipsoriatics: a systematic review","volume":"29","author":"Svendsen MT","year":"2018","unstructured":"Svendsen MT, Andersen F, Andersen KE. eHealth Technologies as an intervention to improve adherence to topical antipsoriatics: a systematic review. J Dermatolog Treat. 2018, 29:123-128. 10.1080\/09546634.2017.1341612","journal-title":"J Dermatolog Treat"},{"key":"ref166","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.3951","article-title":"Impact of mHealth chronic disease management on treatment adherence and patient outcomes: a systematic review","volume":"17","author":"Hamine S","year":"2015","unstructured":"Hamine S, Gerth-Guyette E, Faulx D, Green BB, Ginsburg AS. Impact of mHealth chronic disease management on treatment adherence and patient outcomes: a systematic review. J Med Internet Res. 2015, 17:e52. 10.2196\/jmir.3951","journal-title":"J Med Internet Res"},{"key":"ref167","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1617830","article-title":"Is topical treatment effective for psoriasis in patients who failed topical treatment?","volume":"32","author":"Okwundu N","year":"2021","unstructured":"Okwundu N, Cardwell L, Cline A, Richardson I, Feldman SR. Is topical treatment effective for psoriasis in patients who failed topical treatment?. J Dermatolog Treat. 2021, 32:41-44. 10.1080\/09546634.2019.1617830","journal-title":"J Dermatolog Treat"},{"key":"ref168","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12667","article-title":"A randomized controlled clinical trial to assess the impact of motivational phone calls on therapeutic adherence in patients suffering from psoriasis","volume":"31","author":"Alpalh\u00e3o M","year":"2018","unstructured":"Alpalh\u00e3o M, Antunes J, Gouveia A, et al.. A randomized controlled clinical trial to assess the impact of motivational phone calls on therapeutic adherence in patients suffering from psoriasis. Dermatol Ther. 2018, 31:e12667. 10.1111\/dth.12667","journal-title":"Dermatol Ther"},{"key":"ref169","doi-asserted-by":"publisher","DOI":"10.1186\/s12895-018-0071-3","article-title":"Can an app supporting psoriasis patients improve adherence to topical treatment? A single-blind randomized controlled trial","volume":"18","author":"Svendsen MT","year":"2018","unstructured":"Svendsen MT, Andersen F, Andersen KH, Andersen KE. Can an app supporting psoriasis patients improve adherence to topical treatment? A single-blind randomized controlled trial. BMC Dermatol. 2018, 18:2. 10.1186\/s12895-018-0071-3","journal-title":"BMC Dermatol"},{"key":"ref170","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.02.031","article-title":"Do automated text messages increase adherence to acne therapy? Results of a randomized, controlled trial","volume":"67","author":"Boker A","year":"2012","unstructured":"Boker A, Feetham HJ, Armstrong A, Purcell P, Jacobe H. Do automated text messages increase adherence to acne therapy? Results of a randomized, controlled trial. J Am Acad Dermatol. 2012, 67:1136-1142. 10.1016\/j.jaad.2012.02.031","journal-title":"J Am Acad Dermatol"},{"key":"ref171","doi-asserted-by":"publisher","DOI":"10.5070\/d3212025698","article-title":"Participant satisfaction with appearance-based versus health-based educational videos promoting sunscreen use: a randomized controlled trial","volume":"21","author":"Tuong W","year":"2015","unstructured":"Tuong W, Armstrong AW. Participant satisfaction with appearance-based versus health-based educational videos promoting sunscreen use: a randomized controlled trial. Dermatol Online J. 2015, 21:1. 10.5070\/d3212025698","journal-title":"Dermatol Online J"},{"key":"ref172","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.0859","article-title":"Effect of automated online counseling on clinical outcomes and quality of life among adolescents with acne vulgaris: a randomized clinical trial","volume":"151","author":"Tuong W","year":"2015","unstructured":"Tuong W, Wang AS, Armstrong AW. Effect of automated online counseling on clinical outcomes and quality of life among adolescents with acne vulgaris: a randomized clinical trial. JAMA Dermatol. 2015, 151:970-975. 10.1001\/jamadermatol.2015.0859","journal-title":"JAMA Dermatol"},{"key":"ref173","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15085","article-title":"Teledermatology-driven topical therapy of actinic keratosis: a comparative study of clinical effectiveness and compliance","volume":"32","author":"Ferr\u00e1ndiz L","year":"2018","unstructured":"Ferr\u00e1ndiz L, Morales-Conde M, Fern\u00e1ndez-Orland A, Mart\u00edn-Guti\u00e9rrez FJ, Raya-Maldonado J, Toledo-Pastrana T, Moreno-Ram\u00edrez D. Teledermatology-driven topical therapy of actinic keratosis: a comparative study of clinical effectiveness and compliance. J Eur Acad Dermatol Venereol. 2018, 32:2149-2152. 10.1111\/jdv.15085","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref174","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.277","article-title":"An Internet-based survey and improvement of acne treatment outcomes","volume":"147","author":"Yentzer BA","year":"2011","unstructured":"Yentzer BA, Wood AA, Sagransky MJ, O'Neill JL, Clark AR, Williams LL, Feldman SR. An Internet-based survey and improvement of acne treatment outcomes. Arch Dermatol. 2011, 147:1223-1224. 10.1001\/archdermatol.2011.277","journal-title":"Arch Dermatol"},{"key":"ref175","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14073","article-title":"Secukinumab administration by autoinjector maintains reduction of plaque psoriasis severity over 52 weeks: results of the randomized controlled JUNCTURE trial","volume":"31","author":"Lacour JP","year":"2017","unstructured":"Lacour JP, Paul C, Jazayeri S, et al.. Secukinumab administration by autoinjector maintains reduction of plaque psoriasis severity over 52 weeks: results of the randomized controlled JUNCTURE trial. J Eur Acad Dermatol Venereol. 2017, 31:847-856. 10.1111\/jdv.14073","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref176","doi-asserted-by":"publisher","DOI":"10.2196\/11444","article-title":"Effectiveness of a behavior change technique-based smartphone game to improve intrinsic motivation and physical activity adherence in patients with type 2 diabetes: randomized controlled trial","volume":"7","author":"H\u00f6chsmann C","year":"2019","unstructured":"H\u00f6chsmann C, Infanger D, Klenk C, K\u00f6nigstein K, Walz SP, Schmidt-Trucks\u00e4ss A. Effectiveness of a behavior change technique-based smartphone game to improve intrinsic motivation and physical activity adherence in patients with type 2 diabetes: randomized controlled trial. JMIR Serious Games. 2019, 7:e11444. 10.2196\/11444","journal-title":"JMIR Serious Games"},{"key":"ref177","doi-asserted-by":"publisher","DOI":"10.1097\/JHQ.0000000000000097","article-title":"Enhanced adherence in patients using an automated home medication dispenser","volume":"40","author":"Hoffmann C","year":"2018","unstructured":"Hoffmann C, Schweighardt A, Conn KM, Nelson D, Barbano R, Marshall F, Brown J. Enhanced adherence in patients using an automated home medication dispenser. J Healthc Qual. 2018, 40:194-200. 10.1097\/JHQ.0000000000000097","journal-title":"J Healthc Qual"},{"key":"ref178","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2021.669869","article-title":"Artificial intelligence solutions to increase medication adherence in patients with non-communicable diseases","volume":"3","author":"Babel A","year":"2021","unstructured":"Babel A, Taneja R, Mondello Malvestiti F, Monaco A, Donde S. Artificial intelligence solutions to increase medication adherence in patients with non-communicable diseases. Front Digit Health. 2021, 3:669869. 10.3389\/fdgth.2021.669869","journal-title":"Front Digit Health"},{"key":"ref179","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02954.x","article-title":"Intolerance of isotretinoin in a patient with anhidrotic ectodermal dysplasia","volume":"141","author":"Kirby B","year":"1999","unstructured":"Kirby B, Caird A, Rogers S. Intolerance of isotretinoin in a patient with anhidrotic ectodermal dysplasia. Br J Dermatol. 1999, 141:175. 10.1046\/j.1365-2133.1999.02954.x","journal-title":"Br J Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/290582-current-insights-on-treatment-adherence-in-prevalent-dermatological-conditions-and-strategies-to-optimize-adherence-rates","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T01:27:21Z","timestamp":1726795641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/290582-current-insights-on-treatment-adherence-in-prevalent-dermatological-conditions-and-strategies-to-optimize-adherence-rates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":179,"URL":"https:\/\/doi.org\/10.7759\/cureus.69764","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,19]]}}}